Bruce N. Rogers
2021
In 2021, Bruce N. Rogers earned a total compensation of $2.5M as Chief Scientific Officer at Morphic Holding, a 46% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $211,200 |
|---|---|
| Option Awards | $1,815,235 |
| Salary | $440,000 |
| Other | $8,700 |
| Total | $2,475,135 |
Rogers received $1.8M in option awards, accounting for 73% of the total pay in 2021.
Rogers also received $211.2K in non-equity incentive plan, $440K in salary and $8.7K in other compensation.
Rankings
In 2021, Bruce N. Rogers' compensation ranked 5,188th out of 12,406 executives tracked by ExecPay. In other words, Rogers earned more than 58.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,188 out of 12,406 | 58th |
Division Manufacturing | 2,179 out of 5,492 | 60th |
Major group Chemicals And Allied Products | 940 out of 2,368 | 60th |
Industry group Drugs | 840 out of 2,089 | 60th |
Industry Pharmaceutical Preparations | 603 out of 1,536 | 61st |
Source: SEC filing on April 29, 2022.
Rogers' colleagues
We found four more compensation records of executives who worked with Bruce N. Rogers at Morphic Holding in 2021.
News
Morphic Holding CEO Praveen Tipirneni's 2023 pay slips 15% to $8.9M
April 25, 2024
Morphic Holding CEO Praveen Tipirneni's 2022 pay jumps 93% to $11M
April 21, 2023
Morphic Holding CEO Praveen Tipirneni's 2021 pay jumps 43% to $5.5M
April 29, 2022
Morphic Holding CEO Praveen Tipirneni's 2020 pay jumps 384% to $3.8M
April 29, 2021
Morphic Holding General Counsel William DeVaul receives $790K in 2019
April 30, 2020